All Industries

Top Life Sciences Companies

1,069 Life Sciences companies, sorted by total funding raised.

Cartwheel

School-based telehealth mental health provider partnering with school districts to deliver eviden...

Cambridge, United States51–200EdTech, Healthcare
GrantTotal funding$94.3MOct 2025
Adonis

Adonis is an AI-powered revenue intelligence and automation platform built for healthcare, helpin...

New York, United States11–50Artificial Intelligence, Fintech
Series CTotal funding$93.9MMar 2026
Chemify Limited

Chemify fuses AI, robotics, and its Chemputation programming language to digitize molecule design...

Glasgow, United Kingdom51–200Life Sciences
Series BTotal funding$93.0MOct 2025
Pharmaceutics InternationalAcquired
Drug Discovery, Healthcare
Growth EquityTotal funding$93.0MSep 2016
Doccla

Doccla delivers proactive care at scale, keeping patients well at home and reducing the total cos...

London, United Kingdom51–200Life Sciences, Healthcare
Series BTotal funding$90.0MSep 2024
Tendo Systems

Healthcare technology platform delivering analytics, patient engagement, and a shoppable care mar...

Philadelphia, United States51–200Life Sciences, Data & Analytics
Growth EquityTotal funding$89.0MApr 2025
Conceivable

Reimagining the IVF lab to increase by 10X the number of families who can be helped to conceive.

New York, United States11–50Healthcare, Biotech
Series ATotal funding$88.0MSep 2025
Maxion Therapeutics

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Cambridge, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$88.0MMar 2025
Tempest TherapeuticsIPO

A clinical-stage oncology company advancing small molecules that combine both targeted and immune...

Brisbane, United States11–50Biotech, Drug Discovery
Private EquityTotal funding$85.0MApr 2022
Averna Therapeutics

Averna Therapeutics is developing genomic medicines that insert therapeutic genes into safe harbo...

Watertown, United States11–50Life Sciences, Biotech
Series ATotal funding$82.0MJun 2024
Qualifyze

Founded in 2019, Qualifyze is a leading company in supply chain risk management in the Life Scien...

Frankfurt, Germany51–200Life Sciences, SaaS
Series BTotal funding$82.0MSep 2024
Fay

Fay is a three-sided AI platform connecting patients with registered dietitian nutritionists who ...

New York, United States51–200Life Sciences, Healthcare
Series BTotal funding$80.0MFeb 2025
Mosanna Therapeutics

Mosanna Therapeutics develops a novel pharmaceutical approach to sleep apnea that helps activate ...

Redwood City, United States1–10Biotech, Healthcare
Series ATotal funding$80.0MJun 2025
Zag Bio

Biotech company developing thymus-targeted bifunctional antibody therapies to restore immune tole...

Cambridge, United States11–50Biotech, Life Sciences
Series ATotal funding$80.0MOct 2025
SpringAcquired

Mobile-first shopping marketplace connecting retailers directly to consumers, enabling brands to ...

New York, United StatesLife Sciences, E-Commerce
Series BTotal funding$79.3MSep 2021
Lumen Bioscience, Inc.

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services, Department of A...

Seattle, United States11–50Biotech, Life Sciences
Extension RoundTotal funding$77.0MOct 2025
Abzena

Abzena helps biotechnology and pharmaceutical innovators develop complex biologics and bioconjuga...

Biotech, Drug Discovery
Growth EquityTotal funding$75.0MMar 2022
Evermore

Provides a Smart Benefits platform and card connecting health plan members to retailers and servi...

Bentonville, United States51–200Fintech, Healthcare
Series BTotal funding$75.0MDec 2024
Georgiamune

Clinical-stage biotech building a pipeline of immunomodulators that enhance or inhibit immune sig...

Gaithersburg, United States11–50Life Sciences, Biotech
Series ATotal funding$75.0MAug 2023
IXLayer

Direct-to-patient healthcare platform for biopharma, integrating telehealth, lab testing, and pre...

San Francisco, United States51–200Life Sciences, Healthcare
Series ATotal funding$75.0MMar 2021
Precision BioSciencesIPO

Clinical-stage gene editing company developing in vivo therapies using its proprietary ARCUS geno...

Durham, United States51–200Biotech, Genomics
Venture RoundTotal funding$75.0MJun 2022
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series ETotal funding$72.2MMar 2015
Cirsium Biosciences

We are a collective of innovators, researchers, and scientists committed to revolutionizing the g...

San Diego, United States11–50Life Sciences, Biotech
GrantTotal funding$71.6MOct 2024
Elysium

Develops clinically validated dietary supplements and biological-age tests to help consumers supp...

New York, United States11–50Life Sciences, Healthcare
GrantTotal funding$71.5MJun 2023
SparingVision

SparingVision is a clinical-stage genomic medicines company developing treatments for inherited r...

Biotech, Healthcare
Series BTotal funding$71.0MSep 2022